Viewing Study NCT02776735


Ignite Creation Date: 2025-12-24 @ 10:45 PM
Ignite Modification Date: 2025-12-30 @ 8:40 PM
Study NCT ID: NCT02776735
Status: COMPLETED
Last Update Posted: 2024-10-15
First Post: 2016-05-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)
Sponsor: Sanofi
Organization: